Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Total Assets
Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) holds total assets worth CN¥4.44 Billion CNY (≈ $649.16 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 002755 total equity for net asset value and shareholders' equity analysis.
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's total assets have evolved over time, based on quarterly financial data.
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beijing New Oriental Star Petrochemical Engineering Co Ltd's total assets of CN¥4.44 Billion consist of 63.5% current assets and 36.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 34.9% |
| Accounts Receivable | CN¥244.85 Million | 6.1% |
| Inventory | CN¥196.99 Million | 4.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥794.65 Million | 19.6% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing New Oriental Star Petrochemical market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing New Oriental Star Petrochemical Engineering Co Ltd's current assets represent 63.5% of total assets in 2024, a decrease from 89.8% in 2011.
- Cash Position: Cash and equivalents constituted 34.9% of total assets in 2024, up from 19.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 19.6% of total assets.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Total Assets
Key competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 3.41 | 3.84 |
| Quick Ratio | 2.60 | 3.16 | 3.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.86 Billion | CN¥1.81 Billion | CN¥1.96 Billion |
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beijing New Oriental Star Petrochemical Engineering Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.52 |
| Latest Market Cap to Assets Ratio | 0.57 |
| Asset Growth Rate (YoY) | 14.9% |
| Total Assets | CN¥4.05 Billion |
| Market Capitalization | $2.30 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Beijing New Oriental Star Petrochemical Engineering Co Ltd's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Beijing New Oriental Star Petrochemical Engineering Co Ltd's assets grew by 14.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)
The table below shows the annual total assets of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.05 Billion ≈ $592.30 Million |
+14.86% |
| 2023-12-31 | CN¥3.52 Billion ≈ $515.65 Million |
+3.21% |
| 2022-12-31 | CN¥3.41 Billion ≈ $499.63 Million |
-8.33% |
| 2021-12-31 | CN¥3.72 Billion ≈ $545.05 Million |
-2.19% |
| 2020-12-31 | CN¥3.81 Billion ≈ $557.24 Million |
+3.14% |
| 2019-12-31 | CN¥3.69 Billion ≈ $540.27 Million |
+24.81% |
| 2018-12-31 | CN¥2.96 Billion ≈ $432.89 Million |
+241.37% |
| 2017-12-31 | CN¥866.57 Million ≈ $126.81 Million |
+25.49% |
| 2016-12-31 | CN¥690.57 Million ≈ $101.05 Million |
-3.61% |
| 2015-12-31 | CN¥716.42 Million ≈ $104.84 Million |
+22.96% |
| 2014-12-31 | CN¥582.66 Million ≈ $85.26 Million |
+0.12% |
| 2013-12-31 | CN¥581.97 Million ≈ $85.16 Million |
-3.78% |
| 2012-12-31 | CN¥604.82 Million ≈ $88.50 Million |
+35.54% |
| 2011-12-31 | CN¥446.22 Million ≈ $65.30 Million |
-- |
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more